Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders
Els F. Halff, Grazia Rutigliano, Anna Garcia-Hidalgo, et al.
Trends in Neurosciences (2022) Vol. 46, Iss. 1, pp. 60-74
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 49
Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons
Seongsik Yun, Ben Yang, Justin D. Anair, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 8, pp. 1417-1428
Open Access | Times Cited: 45
Ligand recognition and G-protein coupling of trace amine receptor TAAR1
Zheng Xu, Lulu Guo, Jingjing Yu, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 672-681
Closed Access | Times Cited: 30
Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia
Eric D. Achtyes, Seth C. Hopkins, Nina Dedic, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1543-1556
Open Access | Times Cited: 29
Parkinson disease psychosis: from phenomenology to neurobiological mechanisms
Javier Pagonabarraga, Helena Bejr‐Kasem, Saül Martínez‐Horta, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 3, pp. 135-150
Closed Access | Times Cited: 14
TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding
Nina Dedic, Lien Wang, Éva Hajós‐Korcsok, et al.
Molecular Metabolism (2024) Vol. 80, pp. 101883-101883
Open Access | Times Cited: 8
The Neurometabolic Function of the Dopamine–Aminotransferase System
Sergey A. Apryatin
Metabolites (2025) Vol. 15, Iss. 1, pp. 21-21
Open Access | Times Cited: 1
Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
Spyridon Siafis, Virginia Chiocchia, Malcolm Macleod, et al.
Wellcome Open Research (2024) Vol. 9, pp. 182-182
Open Access | Times Cited: 7
Newly identified structures of trace-amine associated receptor-1 (TAAR1) will aid discovery of next generation neuropsychiatric drugs
Pramod C. Nair, Britto Shajan, Tarun Bastiampillai
Molecular Psychiatry (2024) Vol. 29, Iss. 6, pp. 1925-1928
Closed Access | Times Cited: 6
Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia
Nico Antenucci, Giovanna D’Errico, Francesco Fazio, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling
Giancarlo Grossi, Naomi Scarano, Francesca Musumeci, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1739-1739
Open Access | Times Cited: 6
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment
Ali Azargoonjahromi
Clinical Drug Investigation (2024) Vol. 44, Iss. 7, pp. 471-493
Closed Access | Times Cited: 6
AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1
Alejandro Díaz‐Holguín, Marcus Saarinen, Duc Duy Vo, et al.
Science Advances (2024) Vol. 10, Iss. 32
Open Access | Times Cited: 6
Trace amine signaling in zebrafish models: CNS pharmacology, behavioral regulation and translational relevance
David S. Galstyan, Natalia A. Krotova, A. S. Lebedev, et al.
European Journal of Pharmacology (2025), pp. 177312-177312
Closed Access
The role of rodent behavioral models of schizophrenia in the ongoing search for novel antipsychotics
Hugo Cano-Ramírez, Kurt L. Hoffman
Expert Opinion on Drug Discovery (2025), pp. 1-15
Closed Access
Trace amine-associated receptors (TAARs)2-9 knockout mice exhibit reduced wakefulness and disrupted REM sleep
Sunmee Park, Jasmine Heu, Gavin Scheldrup, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
IUPHAR Review - Novel therapeutic targets for schizophrenia treatment: a translational perspective
Veronica Begni, Alessia Marchesin, Marco Andrea Riva
Pharmacological Research (2025), pp. 107690-107690
Open Access
WWC1 mutation drives dopamine dysregulation and synaptic imbalance in Tourette’s syndrome
Junkai Lv, Shaoyan Liang, Pengwei Qin, et al.
Science Advances (2025) Vol. 11, Iss. 13
Open Access
Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders
Savelii R. Kuvarzin, Ilya Sukhanov, Kirill Onokhin, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1977-1977
Open Access | Times Cited: 11
TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner
Sung Min Yang, Ayan Ghoshal, Jeffrey M. Hubbard, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 7, pp. 1091-1103
Open Access | Times Cited: 9
TAAR1 as an emerging target for the treatment of psychiatric disorders
Jianfeng Liu, Ruyan Wu, Jun‐Xu Li
Pharmacology & Therapeutics (2023) Vol. 253, pp. 108580-108580
Closed Access | Times Cited: 9
TAAR1 in dentate gyrus is involved in chronic stress-induced impairments in hippocampal plasticity and cognitive function
Yue Zhang, Xianqiang Zhang, Wei-Pan Niu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 132, pp. 110995-110995
Closed Access | Times Cited: 3
Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Giuseppe De Simone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5945-5945
Open Access | Times Cited: 7
Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies.
Spyridon Siafis, Robert A. McCutcheon, Virginia Chiocchia, et al.
Wellcome Open Research (2023) Vol. 8, pp. 365-365
Open Access | Times Cited: 7
Up-regulation of the Trace Amine Receptor, TAAR-1, in the Prefrontal Cortex of Individuals Affected by Schizophrenia
Tiziana Imbriglio, Marika Alborghetti, Valeria Bruno, et al.
Schizophrenia Bulletin (2023) Vol. 50, Iss. 2, pp. 374-381
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top